NPC's John O'Brien to Moderate Keynote with Former FDA Commissioner Scott Gottlieb at AVBCC
NPC's John O'Brien will facilitate the keynote discussion with the former FDA commissioner at the upcoming Association for Value-Based Cancer Care (AVBCC) Educational Summit & Program and also serve on a panel to discuss the impact of the IRA's drug pricing provisions.
AVBCC Educational Summit & Program | October 18-20, 2023
The Association for Value-Based Cancer Care (AVBCC) will host this invitation-only event in New York, NY to help stakeholders in the cancer care continuum maximize value by focusing on clinical, cost, and access issues.
NPC President and CEO John M. O’Brien, PharmD, MPH, will participate in two sessions. He will address pressing health policy issues facing the field, including anticipating the impact of implementing the IRA's drug pricing provisions and emerging barriers to continued biopharmaceutical innovation.
Wednesday, October 18 | 10:00 AM - 10:50 AM
IRA Healthcare Industry: Translating Impact Over the Next 5 Years
Moderator:
- Jayson Slotnik, JD, MPH, Partner, Health Policy Strategies
Faculty:
- Muna Tuna, US Market Pricing and Reimbursement Leader, Ernest & Young, LLP
- Luke Greenwalt, Vice President and Lead Market Access Center of Excellence, IQVIA
- Jeff Allen, PhD, President & CEO, Friends of Cancer Research
- John O'Brien, PharmD, MPH, President & CEO, National Pharmaceutical Council
Wednesday, October 18 | 12:30 PM - 1:20 PM
Keynote with Scott Gottlieb, MD, Former Commissioner, FDA
Moderator:
- John O'Brien, PharmD, MPH, President & CEO, National Pharmaceutical Council
Faculty:
- Scott Gottlieb, MD, Former Commissioner, FDA
For more information or to request an invitation, visit the AVBCC website.